From Medscape Oncology

Medscape Medical News from the:

American Society of Clinical Oncology (ASCO®) 2010 Annual Meeting

June 04 - 08, 2010; Chicago, Illinois

This coverage is not sanctioned by, nor a part of, the American Society of Clinical Oncology.


Top News Stories From the ASCO ® 2010 Annual Meeting: Slideshow
Research highlights include striking results with eribulin for metastatic breast cancer, a beneficial antiangiogenic agent for ovarian cancer, a possible new standard of care for advanced melanoma, and an ALK inhibitor for NSCLC.

Oncology Insights: The Wrap-up

ASCO ® 2010 Wrap-up: Converting Cancer to a Chronic Disease
A roundtable discussion between Dr. Maurie Markman, Dr. Kathy Miller, Dr. John Marshall, Dr. Mark Kris, and Dr. Richard Schilsky highlighting issues arising from the ASCO 2010 presentations.

Conference News


The materials presented here do not reflect the views of WebMD, LLC. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers should verify all information and data before treating patients or employing any therapies described in this article.

The materials presented here were prepared by independent authors under the editorial supervision of WebMD, LLC, and do not represent a publication of the American Society of Clinical Oncology. These materials are not sanctioned by the American Society of Clinical Oncology and do not constitute an official part of the conference.

Medscape Oncology©  WebMD, LLC

Medscape Oncology Insights: Personalized Medicine

What Will It Take to Maximize Personalized Medicine?
Maurie L. Markman, MD; Richard L. Schilsky, MD